Carotid stenting: an open question
Recent controversy led by interventional stent TCT 2006 Press Conference WASHINGTON, DC, October 24, 2006 Two recent European studies have raised concerns about the safety and efficacy of carotid stenting in symptomatic patients, but interventionist leaders say that it is still an open question, and addressed the issue during a news conference Wednesday at the Transcatheter Cardiovascular Therapeutics symposium (TCT 2006).* Since it is proposed as an alternative to carotid surgery? * What is the status of today carotid stenting? * What are the data from two European studies (the French EVA-3S study space for studying and German)? * What is the evidence of speaking European carotid artery in symptomatic patients? * What are the weaknesses and difficulties of two new
studies? * What happens in the United States to questions about carotid stenting as an alternative to carotid surgery answer? * When we can provide a definitive answer from the U.S. Studies?WHEN: Wednesday, October 25th PLACE: TCT 2006 at Washington Convention Center WHO: The press conference by William A. Gray, MD, Director of Endovascular Services at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital / Columbia University Medical Center and was moderated associate professor of clinical medicine at Columbia University College of Physicians and Surgeons. The conference panelists were: * L. Nelson Hopkins, MD
Subbarao Myla *, MD, Medical Director, Heart and Vascular Center, Fountain Valley * Klaus Mathias, MD, Clinical Center of MiddleDortmund, Dortmund, Germany * Jay Yadav, MD, President of CardioMEMS Inc. * Michael Jaff, DO, FACC, the Massachusetts General Hospital ---------------------------- Article adapted by Medical News Today from original press release.